Inactive Instrument

Company ViaDerma, Inc. Other OTC

Equities

VDRM

US92555K1016

Biotechnology & Medical Research

Business Summary

ViaDerma, Inc. is a specialty pharmaceutical company engaged in bringing new products to market and licensing its transdermal drug delivery technology solutions. The Company’s lead product is a topical antibiotic, which is focused on being sold under the brand name Vitastem. In addition to licensing its proprietary transdermal technologies, its lead product, Vitastem, is available for treating multiple skin conditions and ailments. The Company also has products in development in fields, such as anti-aging skin care, pain management, hair-loss, and toenail fungus. The products are based on a delivery system technology that allows for rapid mass transfer of the pharmaceutical active ingredient across the skin and into the body to provide immediate localized therapy. The Company’s products are sold to local medical practitioners and patients in clinics primarily in the Los Angeles, California area. The Company’s subsidiary is ViaDerma, II Inc.

Sales per Business

USD in Million2022Weight2023Weight Delta
Topical Antibiotic
100.0 %
1 100.0 % 1 100.0 % +11.07%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
100.0 %
1 100.0 % 1 100.0 % +11.07%

Managers

Managers TitleAgeSince
Chief Executive Officer - 14-03-30

Members of the board

Members of the board TitleAgeSince
Chief Executive Officer - 14-03-30

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,228,143,498 1,215,862,063 ( 99.00 %) 0 99.00 %

Company contact information

ViaDerma, Inc.

4640 Admiralty Way Suite 500

90292, Marina Del Rey

+

address ViaDerma, Inc.(VDRM)